Immunome Inc. financial data

Symbol
IMNM on Nasdaq
Location
Bothell, WA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 790% % 5.8%
Debt-to-equity 15% % -8.7%
Return On Equity -87% % 38%
Return On Assets -76% % 37%
Operating Margin -2420% % 23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 91,710,277 shares 47%
Common Stock, Shares, Outstanding 91,706,948 shares 52%
Entity Public Float $642,700,000 USD 751%
Common Stock, Value, Issued $9,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 87,957,868 shares 46%
Weighted Average Number of Shares Outstanding, Diluted 87,957,868 shares 46%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $9,679,000 USD -4.4%
Research and Development Expense $174,406,000 USD 91%
General and Administrative Expense $42,123,000 USD 38%
Operating Income (Loss) $234,222,000 USD 26%
Net Income (Loss) Attributable to Parent $222,743,000 USD 27%
Earnings Per Share, Basic -2 USD/shares 66%
Earnings Per Share, Diluted -2 USD/shares 66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $272,639,000 USD 75%
Assets, Current $279,924,000 USD 15%
Property, Plant and Equipment, Net $11,563,000 USD 61%
Operating Lease, Right-of-Use Asset $3,125,000 USD 31%
Other Assets, Noncurrent $4,555,000 USD 42%
Assets $299,377,000 USD 17%
Accounts Payable, Current $6,147,000 USD 75%
Employee-related Liabilities, Current $7,171,000 USD 117%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $31,445,000 USD -20%
Contract with Customer, Liability, Noncurrent $2,208,000 USD -77%
Deferred Income Tax Liabilities, Net $1,033,000 USD 173%
Operating Lease, Liability, Noncurrent $4,013,000 USD 63%
Liabilities $35,458,000 USD -16%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD -100%
Retained Earnings (Accumulated Deficit) $658,264,000 USD -51%
Stockholders' Equity Attributable to Parent $263,919,000 USD 23%
Liabilities and Equity $299,377,000 USD 17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $53,055,000 USD -375%
Net Cash Provided by (Used in) Financing Activities $162,228,000 USD -26%
Net Cash Provided by (Used in) Investing Activities $5,089,000 USD
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 91,706,948 shares 52%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $114,262,000 USD -33%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $272,849,000 USD 75%
Deferred Tax Assets, Valuation Allowance $106,720,000 USD 168%
Deferred Tax Assets, Gross $107,753,000 USD 168%
Operating Lease, Liability $4,013,000 USD 47%
Payments to Acquire Property, Plant, and Equipment $3,665,000 USD 69%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $222,813,000 USD 27%
Lessee, Operating Lease, Liability, to be Paid $17,172,000 USD 361%
Operating Lease, Liability, Current $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,330,000 USD 177%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,468,000 USD 67%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $3,821,000 USD 504%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,383,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $29,346,000 USD 29%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $56,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,616,000 USD
Additional Paid in Capital $922,174,000 USD 42%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $611,000 USD 289%
Deferred Tax Assets, Net of Valuation Allowance $1,033,000 USD 173%
Share-based Payment Arrangement, Expense $23,267,000 USD 77%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%